Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.
Hepatology communications
View this publicationHepatology communications
View this publicationAnnals of surgical oncology
View this publicationScientific reports
View this publicationArchives of Iranian medicine
View this publicationImmunology letters
View this publicationHuman brain mapping
View this publicationFrontiers in immunology
View this publicationAlzheimer's research & therapy
View this publicationMolecular psychiatry
View this publicationNutrients
View this publication